Mukherjee, Sandeep <br/><br/>
Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.  [electronic resource] 

 -  Journal of gastroenterology and hepatology  Jun 2004 
 - 723-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>0815-9319 
<br/><br/><label>Standard No.: </label>10.1111/j.1440-1746.2004.03452.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Chemical and Drug Induced Liver Injury<br/>Female<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Male<br/>Polyethylene Glycols<br/>Recombinant Proteins<br/>Recurrence<br/>Ribavirin--adverse effects